Call (844) 879-2237

Home » Uncategorized » Acera to Start Clinical Trial on Restrata™ Wound Matrix

Acera to Start Clinical Trial on Restrata™ Wound Matrix

St. Louis, MO. September 15, 2017- Acera is starting a clinical trial on Restrata™ Wound Matrix with a focus on diabetic foot ulcer.  Acera will be working with Telos Partner to manage the clinical trial. The study is titled: “Clinical Outcomes after Treatment with Restrata™ in Diabetic Foot Ulcers (DFU): A Case Series of Initial Effectiveness and Safety Measures.”

Please click here to read more from  Telos Partners’ press release.

 

Comments are closed.